FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease
The National Cancer Institute (NCI) has awarded Mayo Clinic (Rochester), in partnership with SOFIE, a […]
Dulles, VA – January 17, 2023 – SOFIE Biosciences (SOFIE), an established US manufacturer and developer […]
Dulles, VA – November 29, 2022 – SOFIE Biosciences (SOFIE), an established US manufacturer and developer […]
A WORD FROM OUR CHIEF SCIENTIFIC OFFICER
We are excited to launch our FAPI newsletter […]
Dulles, VA – October 31, 2022 – SOFIE Biosciences (SOFIE), an established US manufacturer and developer […]
SOFIE Biosciences (SOFIE), an established US manufacturer and developer of radiopharmaceuticals, has dosed and imaged […]